SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
_________________
Form
8-K
_________________
Current
Report
Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of 1934
January
18, 2008
Date
of Report
(Date
of earliest event reported)
_________________
A.P.
PHARMA, INC.
(Exact
name of Registrant as specified in its charter)
_________________
|
Delaware
|
000-33221
|
94-2875566
|
||
|
(State
or other jurisdiction of
incorporation
or organization)
|
(Commission
File Number)
|
(I.R.S.
Employer
Identification
No.)
|
123
Saginaw Drive
Redwood
City, California 94063
(Address
of principal executive offices) (Zip code)
(650)
366-2626
(Registrant’s
telephone number, including area code)
(Former
name or former address, if changed since last report)
_________________
Check
the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions:
|
¨
|
Written
communications pursuant to Rule 425 under the Securities Act (17
CFR
230.425)
|
|
¨
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
|
|
¨
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17
CFR
240.14d-2(b))
|
|
¨
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17
CFR
240.13e-4(c))
|
_________________
Item
5.02. Departure of Directors or Principal Officers; Election of Directors;
Appointment of Certain Officers; Compensatory Arrangements of Certain
Officers
(b) Effective
January 18,
2008, Michael O’Connell resigned from the Board of Directors of A.P. Pharma,
Inc.
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the Registrant
has
duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
|
A.P.
PHARMA, INC.
|
||||
|
Date:
January 24, 2008
|
By:
|
/s/
Gregory Turnbull
_________________
|
||
|
Name:
Gregory Turnbull
|
||||
|
Title: President
and Chief Executive Officer
|
||||